Literature DB >> 33915228

Targeted RNA sequencing of adrenal zones using immunohistochemistry-guided capture of formalin-fixed paraffin-embedded tissue.

Jessica E Baker1, Samuel W Plaska1, Zhaoping Qin2, Chia-Jen Liu3, Juilee Rege1, William E Rainey4, Aaron M Udager5.   

Abstract

Adequate access to fresh or frozen normal adrenal tissue has been a primary limitation to the enhanced characterization of the adrenal zones via RNA sequencing (RNAseq). Herein, we describe the application of targeted RNAseq to formalin-fixed paraffin-embedded (FFPE) normal adrenal gland specimens. Immunohistochemistry (IHC) was used to visualize and guide the capture of the adrenocortical zones and medulla. Following IHC-based tissue capture and isolation of RNA, high-throughput targeted RNAseq highlighted clear transcriptomic differences and identified differentially expressed genes among the adrenal zones. Our data demonstrate the ability to capture FFPE adrenal zone tissue for targeted transcriptomic analyses. Future comparison of normal adrenal zones will improve our understanding of transcriptomic patterns and help identify potential novel pathways controlling zone-specific steroid production.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenal cortex; Adrenal medulla; RNAseq; Zona fasciculata; Zona glomerulosa; Zona reticularis

Mesh:

Year:  2021        PMID: 33915228      PMCID: PMC8456741          DOI: 10.1016/j.mce.2021.111296

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.369


  43 in total

1.  Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla.

Authors:  Stephanie M J Fliedner; Jan Breza; Richard Kvetnansky; James F Powers; Arthur S Tischler; Robert Wesley; Maria Merino; Hendrik Lehnert; Karel Pacak
Journal:  Cell Tissue Res       Date:  2010-04-30       Impact factor: 5.249

2.  Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies.

Authors:  T Suzuki; H Sasano; J Takeyama; C Kaneko; W A Freije; B R Carr; W E Rainey
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

Review 3.  Common mechanisms of hormone secretion.

Authors:  J M Trifaró
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

4.  Transcriptome analysis of primary aldosteronism in adrenal glands and controls.

Authors:  Chenlong Chu; Chenhui Zhao; Zhiwei Zhang; Mingwei Wang; Zhaohui Zhang; Anqing Yang; Binbin Ma; Meizhen Gu; Renjie Cui; Zhixiang Xin; Tao Huang; Wenlong Zhou
Journal:  Int J Clin Exp Pathol       Date:  2017-09-01

5.  The human adrenal gland with special reference to the vasculature.

Authors:  J W Dobbie; T Symington
Journal:  J Endocrinol       Date:  1966-04       Impact factor: 4.286

6.  Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer.

Authors:  R J Auchus; T C Lee; W L Miller
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

7.  Assessment of the ability of type 2 cytochrome b5 to modulate 17,20-lyase activity of human P450c17.

Authors:  Penny Soucy; Van Luu-The
Journal:  J Steroid Biochem Mol Biol       Date:  2002-01       Impact factor: 4.292

Review 8.  Catecholamine release from the adrenal medulla.

Authors:  R L Perlman; M Chalfie
Journal:  Clin Endocrinol Metab       Date:  1977-11

9.  Dehydroepiandrosterone sulfotransferase localization in human adrenal glands: a light and electron microscopic study.

Authors:  A R Kennerson; D A McDonald; J B Adams
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

10.  Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.

Authors:  Samuel W Plaska; Chia-Jen Liu; Jung Soo Lim; Juilee Rege; Nolan R Bick; Antonio M Lerario; Gary D Hammer; Thomas J Giordano; Tobias Else; Scott A Tomlins; William E Rainey; Aaron M Udager
Journal:  Horm Metab Res       Date:  2020-08-13       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.